title: Acute leukemia after infliximab therapy.
authors.forename: Guillermo
authors.initials: G
authors.lastname: Alcaín
authors.forename: Raúl J
authors.initials: RJ
authors.lastname: Andrade
authors.forename: María P
authors.initials: MP
authors.lastname: Queipo de Llano
authors.forename: María J
authors.initials: MJ
authors.lastname: Moreno
authors.forename: Miren
authors.initials: M
authors.lastname: García-Cortés
authors.forename: Eduardo
authors.initials: E
authors.lastname: Franquelo
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D003424:Crohn Disease / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004322:Drainage / Q000379:methods; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D007412:Intestinal Fistula / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000139:chemically induced*; D018570:Risk Assessment; D012720:Severity of Illness Index
chemical_list: D000911:Antibodies, Monoclonal; D000069285:Infliximab